E
Ekramy E. Sayedahmed
Researcher at Purdue University
Publications - 14
Citations - 168
Ekramy E. Sayedahmed is an academic researcher from Purdue University. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 6, co-authored 10 publications receiving 93 citations.
Papers
More filters
Journal ArticleDOI
Vaccine approaches conferring cross-protection against influenza viruses.
TL;DR: It seems that the development of a universal influenza vaccine is feasible, which would revolutionize the strategy for influenza pandemic preparedness, and significantly impact the shelf-life and protection efficacy of seasonal influenza vaccines.
Journal ArticleDOI
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines.
TL;DR: The Ad vector-based vaccine platform offers a robust egg-independent production system for manufacturing large numbers of influenza vaccines inexpensively in a short timeframe and their potential in designing a universal influenza vaccine is discussed.
Journal ArticleDOI
Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
Ahmed O. Hassan,Omar Amen,Omar Amen,Ekramy E. Sayedahmed,Sai V. Vemula,Samuel Amoah,Ian A. York,Shivaprakash Gangappa,Suryaprakash Sambhara,Suresh K. Mittal +9 more
TL;DR: Results suggest that the ME vaccine approach provided broad protection against the avian influenza viruses, and further improvement of this vaccine will lead to a pre-pandemic vaccine that may lower morbidity, hinder transmission, and prevent mortality in a pandemic situation before a strain-matched vaccine becomes available.
Journal ArticleDOI
Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy
Ekramy E. Sayedahmed,Rashmi Kumari,Shruti Shukla,Ahmed O. Hassan,Sulma I. Mohammed,Ian A. York,Shivaprakash Gangappa,Suryaprakash Sambhara,Suresh K. Mittal +8 more
TL;DR: There was a significant continual decrease in vector immunity titers with time, thereby leading to significant continual increases in the levels of HA-specific humoral and cell-mediated immune responses.
Book ChapterDOI
Current Use of Adenovirus Vectors and Their Production Methods.
TL;DR: Some of the current usages of AdV vectors and their production methods are emphasized, which have a wide range of applications for different clinical settings.